Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation
- PMID: 35834993
- DOI: 10.1016/j.biopha.2022.113375
Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: Involved with the fundamental role of neuroinflammation
Abstract
Objective: To establish an Alzheimer's disease (AD) mouse model, investigate the behavioral performance changes and intracerebral molecular changes induced by bilateral intracerebroventricular injection of streptozotocin (STZ/I.C.V), and explore the potential pathogenesis of AD.
Methods: An AD mouse model was established by STZ/I.C.V. The behavioral performance was observed via the open field test (OFT), novel object recognition test (NOR), and tail suspension test (TST). The mRNA and protein expressions of interleukin 1β (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor α (TNF-α) in the hippocampus were measured via qPCR and Western blot. The expression of β-amyloid 1-42 (Aβ1-42), phosphorylated Tau protein (p-Tau (Ser396)), Tau5, β-site amyloid precursor protein (APP) cleaving enzyme (BACE), insulin receptor substrate 1 (IRS1), brain-derived neurotrophic factor (BDNF), Copine6, synaptotagmin-1 (Syt-1), synapsin-1, phosphoinositol 3 kinase (PI3K), serine/threonine kinase (Akt), phosphorylated serine/threonine kinase (p-Akt (Ser473)), triggering receptor expressed on myeloid cells-1/2 (TREM1/2) were detected using Western blot, and the expression of glial fibrillary acidic protein (GFAP), ionized calcium binding adapter molecule 1 (IBA1), Aβ1-42, p-Tau(Ser396), Syt-1, BDNF were measured via immunofluorescence staining.
Results: STZ/I.C.V induced AD-like neuropsychiatric behaviors in mice, as indicated by the impairment of learning and memory, together with the reduced spontaneous movement and exploratory behavior. The expression of BACE, Aβ1-42, p-Tau(Ser396), and TREM2 were significantly increased in the hippocampus of model mice, while the expression of IRS1, BDNF, Copine6, Syt-1, synapsin-1, PI3K, p-Akt(Ser473), and TREM1 were decreased as compared with that of the controls. Furthermore, the model mice presented a hyperactivation of astrocytes and microglia in the hippocampus, accompanied by the increased mRNA and protein expressions of IL-1β, IL-6 and TNF-α.
Conclusion: STZ/I.C.V is an effective way to induce AD mice model, with not only AD-like neuropsychiatric behaviors, but also typic AD-like neuropathological features including neurofibrillary tangles, deposit of β-amyloid (Aβ), neuroinflammation, and imbalanced synaptic plasticity.
Keywords: Alzheimer’s disease; Neuroinflammation; Streptozotocin; Synaptic plasticity.
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Conflict of interest statement The authors declare that there are no conflicts of interest.
Similar articles
-
Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology.J Neuroinflammation. 2022 Feb 7;19(1):35. doi: 10.1186/s12974-022-02393-2. J Neuroinflammation. 2022. PMID: 35130907 Free PMC article.
-
Resveratrol ameliorates learning and memory impairments induced by bilateral hippocampal injection of streptozotocin in mice.Neurochem Int. 2022 Oct;159:105385. doi: 10.1016/j.neuint.2022.105385. Epub 2022 Jul 16. Neurochem Int. 2022. PMID: 35843421
-
Protective effect of melatonin against metabolic disorders and neuropsychiatric injuries in type 2 diabetes mellitus mice.Phytomedicine. 2024 Aug;131:155805. doi: 10.1016/j.phymed.2024.155805. Epub 2024 Jun 4. Phytomedicine. 2024. PMID: 38851097
-
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.Prog Neurobiol. 2013 Jul-Aug;106-107:33-54. doi: 10.1016/j.pneurobio.2013.06.002. Epub 2013 Jul 1. Prog Neurobiol. 2013. PMID: 23827971 Review.
-
Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer's Disease.Cells. 2022 May 24;11(11):1735. doi: 10.3390/cells11111735. Cells. 2022. PMID: 35681431 Free PMC article. Review.
Cited by
-
Evaluation of the Sporadic Anti-Alzheimer's Activity of Purpurin Using In Silico, In Vitro, and In Vivo Approaches.Mol Neurobiol. 2025 Aug;62(8):10443-10467. doi: 10.1007/s12035-025-04910-9. Epub 2025 Apr 10. Mol Neurobiol. 2025. PMID: 40210836
-
Evaluation of the Anti-Alzheimer Activity of Lycium barbarum Polysaccharide in Aβ1-42-Induced Neurotoxicity in Rat Model.Curr Issues Mol Biol. 2025 Mar 26;47(4):226. doi: 10.3390/cimb47040226. Curr Issues Mol Biol. 2025. PMID: 40699625 Free PMC article.
-
New insights in animal models of neurotoxicity-induced neurodegeneration.Front Neurosci. 2024 Jan 8;17:1248727. doi: 10.3389/fnins.2023.1248727. eCollection 2023. Front Neurosci. 2024. PMID: 38260026 Free PMC article. Review.
-
Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM.J Diabetes Res. 2024 Jul 3;2024:5661751. doi: 10.1155/2024/5661751. eCollection 2024. J Diabetes Res. 2024. PMID: 38988702 Free PMC article.
-
Neuroprotective Effects of a Benzofuran-Containing Selenium in a Mouse Alzheimer's Disease Model: Molecular, Biochemical, and Behavioral Analyses.ACS Chem Neurosci. 2025 Jul 2;16(13):2420-2434. doi: 10.1021/acschemneuro.5c00139. Epub 2025 Jun 16. ACS Chem Neurosci. 2025. PMID: 40523837 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous